WTX-124 is a novel IL-2 pro-drug that is conditionally activated in tumors and drives anti-tumor immunity by activating tumor infiltrating CD8+T cellsChristopher J. Nirschl,Heather R. Brodkin,Daniel J. Hicklin,Nesreen Ismail,Kristin Morris,Andres Salmeron,Cynthia Seidel-Dugan,Philipp Steiner,Zoe Steuert,Jenna M. Sullivan,William M. WinstonCANCER RESEARCH(2022)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要